Inhibiting effect of eplerenone for activation/proliferation of helper T cells of chronic heart failure patients
A technology for chronic heart failure and eplerenone, which is applied to medical preparations containing active ingredients, allergic diseases, organic active ingredients, etc., and can solve problems such as ALD escape
Image
Examples
Embodiment 1
[0026] 1. Materials and methods
[0027] 1.1 Materials
[0028] 1.1.1 Experimental objects and case screening conditions Experimental group: 30 cases, all inpatients in the Department of Heart Failure, The First Affiliated Hospital of Xinjiang Medical University, including 18 males and 12 females, aged 32-69 (48.34±4.86) years old . Inclusion criteria: (a) diagnosed with CHF for at least 3 months; (b) NYHA cardiac function class 2-3; exclusion criteria: (a) acute and chronic infection, inflammatory disease; (b) autoimmune disease; (c) recent unstable angina pectoris and acute myocardial infarction (within 3 months); (d) rheumatic diseases with recent (within 3 months) rheumatic activity; (e) diabetes, hyperthyroidism or other endocrine diseases; ( f) Recent use of drugs that affect the immune response (such as corticosteroids); (g) severe liver and renal insufficiency; (h) tumors; (i) pregnancy. Control group: 20 cases, all selected from outpatient health checkups, 10 males...
PUM
Login to View More Abstract
Description
Claims
Application Information
- IPC
- A61K31/585; A61P9/04; A61P37/06
- Inventors
- 程路峰; 伊力哈木江·克尤木



